These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 30376155)

  • 1. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J; Nevitt SJ
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ; Regan KH
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001021. PubMed ID: 29607494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antibiotics for bronchiectasis.
    Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled antibiotics for long-term therapy in cystic fibrosis.
    Ryan G; Singh M; Dwan K
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001021. PubMed ID: 21412868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
    Southern KW; Solis-Moya A; Kurz D; Smith S
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Smith S; Forrester DL; Smyth AR
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.